[Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients]

Gan To Kagaku Ryoho. 1996 May;23(6):797-800.

[Article in Japanese]

Authors

T Izumi¹, K Muroi, Y Hoshino, N Komatsu, T Ohtsuki, M Yamada, H Tomizuka, K Hatake, S Furusawa, Y Miura

Affiliation

¹ Dept. of Medicine, Jichi Medical School, Japan.

PMID: 8645033

No abstract available

Publication types

Clinical Trial

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cyclophosphamide / administration & dosage
Drug Administration Schedule
Epirubicin / administration & dosage
Female
Filgrastim
Granulocyte Colony-Stimulating Factor / therapeutic use
Humans
Lymphoma, Non-Hodgkin / drug therapy*
Male
Prednisone / administration & dosage
Recombinant Proteins / therapeutic use
Remission Induction
Vincristine / administration & dosage

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Epirubicin
Vincristine
Cyclophosphamide
Filgrastim
Prednisone

Supplementary concepts

CEOP protocol 1